Aquestive Therapeutics raises $77.5M in public offering; over-allotment exercised

Aquestive Therapeutics, Inc.

Underwriters exercised over-allotment for 559,801 shares at $4.50 on April 22, 2024.
Total gross proceeds approximate $77.5M from 17.2M shares issued.
Offering co-managed by Leerink Partners, Piper Sandler; Oppenheimer as lead manager.
Over-allotment exercised 30 days after initial closing of March 22, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.